Anteris Technologies Ltd
OTC: AMEUF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Wayne Geoffrey Paterson
- Headquarters
- Toowong, Australia
- IPO year
- 2013
- Market cap
- $120.5M
- Website
- https://www.anteristech.com
Loading AMEUF…
Loading profile data…Frequently asked questions about AMEUF
What does Anteris Technologies Ltd (AMEUF) do?
Anteris Technologies Ltd. is a medical device company focused on structural heart solutions. The firm manufactures and commercializes ADAPT, an advanced regenerative tissue product. Additionally, Anteris is actively developing DurAVRTM, a novel 3D, single-piece aortic valve designed to treat aortic stenosis. The company also conducts research an...
Where does AMEUF trade?
Anteris Technologies Ltd (AMEUF) trades on the Other OTC.
What sector is AMEUF in?
Anteris Technologies Ltd (AMEUF) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Anteris Technologies Ltd?
Wayne Geoffrey Paterson is the chief executive officer of Anteris Technologies Ltd (AMEUF).
Where is Anteris Technologies Ltd headquartered?
Anteris Technologies Ltd is headquartered in Australia.
Does AMEUF pay a dividend?
Anteris Technologies Ltd (AMEUF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AMEUF go public?
Anteris Technologies Ltd (AMEUF) completed its initial public offering in 2013.